PMC:7463108 / 14519-14800
Annnotations
LitCovid-PD-FMA-UBERON
| Id | Subject | Object | Predicate | Lexical cue | fma_id |
|---|---|---|---|---|---|
| T92463 | 27-30 | Body_part | denotes | HIV | http://purl.org/sig/ont/fma/fma278683 |
| T48606 | 129-133 | Body_part | denotes | cell | http://purl.org/sig/ont/fma/fma68646 |
LitCovid-PD-CLO
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T73862 | 129-138 | http://purl.obolibrary.org/obo/CL_0000000 | denotes | cell type |
| T23496 | 160-164 | http://purl.obolibrary.org/obo/CLO_0001185 | denotes | 2018 |
LitCovid-PubTator
| Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id |
|---|---|---|---|---|---|
| 235 | 201-204 | Gene | denotes | Tat | Gene:6898 |
| 249 | 27-30 | Species | denotes | HIV | Tax:12721 |
| 250 | 224-232 | Chemical | denotes | morphine | MESH:D009020 |
LitCovid-sentences
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T183 | 21-118 | Sentence | denotes | 2014) HIV expression, depending on the nature and duration of exposure (see Fig. 9; Berman et al. |
| T184 | 119-159 | Sentence | denotes | 2006) and cell type involved (Kim et al. |
| T185 | 160-166 | Sentence | denotes | 2018). |
| T186 | 167-271 | Sentence | denotes | Depending on the outcome measure, Tat expression reduces morphine’s efficacy and potency (Fitting et al. |
2_test
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| 32876803-25338959-62957954 | 21-25 | 25338959 | denotes | 2014 |
| 32876803-18040811-62957955 | 119-123 | 18040811 | denotes | 2006 |